|
This is an index of adverse event reports related to Invirase (Saquinavir). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (64)
Cases resulting in a serious event (64)
Cases resulting in death (2)
Cases resulting in life threatening events (5)
Cases resulting in hospitalization (21)
Cases resulting in disability (11)
Cases resulting in other serious reactions (15)
Below is a sample of adverse event reports reports related to Invirase (Saquinavir). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 23 year old female receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19
Patient: 23 year old female
Adverse reactions / side effects: Complication of Pregnancy
Suspect drug(s):
Epzicom
Administration route: Oral
Indication: Acute HIV Infection
Start date: 2007-10-04
Invirase
Dosage: total daily dose: 600mg/300mg
Administration route: Oral
Indication: Acute HIV Infection
Start date: 2007-10-04
Adverse event in male receiving Invirase (Saquinavir)
Reported by a physician from United States on 2007-10-17
Patient: male, weighing 2.6 kg (5.7 pounds)
Adverse reactions / side effects: Congenital Toxoplasmosis
Suspect drug(s):
AZT
Indication: HIV Infection
Start date: 2002-06-10
End date: 2002-06-20
Combivir
Indication: HIV Infection
Start date: 2002-02-12
Invirase
Indication: HIV Infection
Start date: 2002-05-23
Kaletra
Indication: HIV Infection
Start date: 2002-02-12
Adverse event in male receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from United States on 2007-10-17
Patient: male
Adverse reactions / side effects: Unevaluable Event
Adverse event resulted in: hospitalization
Suspect drug(s):
Invirase (Saquinavir)
Adverse event in 46 year old male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-15
Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Coronary Artery Disease
Adverse event resulted in: disablity
Suspect drug(s):
Combivir
Indication: HIV Infection
Start date: 2005-01-31
End date: 2005-09-21
Invirase
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Kaletra
Indication: HIV Infection
Start date: 2005-01-31
Norvir
Indication: HIV Infection
Start date: 2006-01-11
Trizivir
Indication: HIV Infection
Start date: 2005-09-21
Zerit
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Adverse event in 52 year old male receiving Invirase (Saquinavir)
Reported by a physician from France on 2007-10-15
Patient: 52 year old male
Adverse reactions / side effects: Optic Neuritis Retrobulbar
Adverse event resulted in: disablity
Suspect drug(s):
Bactrim DS
Dosage: also received on 28 september 2005 and 23 june 2006.
Indication: Drug USE FOR Unknown Indication
Start date: 1998-10-27
Combivir
Dosage: reported dosing amount: 2 doses daily.
Start date: 2005-09-28
End date: 2006-06-23
Combivir
Start date: 1999-05-11
End date: 1999-08-01
Combivir
Start date: 2001-03-23
Invirase
Dosage: reported dosing amount: 4 doses daily.
Start date: 2006-06-23
Invirase
Start date: 2002-03-18
Lyrica
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
Neurontin
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
Norvir
Dosage: also received on 15 october 2004, 29 march 2005, 28 september 2005, 17 june 2005 and 23 june 2006.
Start date: 2004-04-17
Norvir
Start date: 1999-09-21
Norvir
Start date: 2000-06-06
Norvir
Start date: 2001-03-23
Norvir
Start date: 2002-03-18
Retrovir
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-23
Retrovir
Start date: 2005-06-17
Telzir
Dosage: reported dosing amount: 2 doses daily. also received on 17 june 2005.
Start date: 2005-03-29
End date: 2006-06-23
Viread
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-23
Viread
Start date: 2003-01-03
Viread
Start date: 2003-09-12
Viread
Start date: 2004-04-17
Viread
Start date: 2004-10-15
Viread
Start date: 2005-03-29
Viread
Start date: 2005-06-17
Other drugs received by patient: Sustiva; Videx; Videx; Videx; Zerit; Zerit; Zerit; Zerit; Hivid; Hivid; Crixivan; Crixivan; 1 Concomitant Drug; Epivir; Agenerase; Kaletra; Kaletra; Fuzeon; Fuzeon; 1 Concomitant Drug; 1 Concomitant Drug; Ziagen; Tercian; Laroxyl; Tenofovir
Adverse event in male receiving Invirase (Saquinavir)
Reported by a individual with unspecified qualification from United States on 2007-10-12
Patient: male
Adverse reactions / side effects: Congenital Toxoplasmosis, Cerebral Ventricle Dilatation, Hepatosplenomegaly
Suspect drug(s):
Combivir
Indication: Drug Exposure During Pregnancy
Invirase
Indication: Drug Exposure During Pregnancy
Kaletra
Indication: Drug Exposure During Pregnancy
Retrovir
Indication: Drug Exposure During Pregnancy
Adverse event in 44 year old male receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from France on 2007-10-11
Patient: 44 year old male
Adverse reactions / side effects: Optic Atrophy, Glaucoma, Optic Nerve Disorder, Drug Ineffective, Tooth Abscess, Trigeminal Neuralgia, Sciatica, Tooth Extraction, Visual Acuity Reduced, Treatment Noncompliance, Balance Disorder, Leukoencephalopathy, Depression, Optic Neuritis Retrobulbar, Facial Pain, Mononeuropathy Multiplex, Visual Disturbance, Gastrointestinal Disorder, Memory Impairment, Neuralgia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Bactrim
Start date: 1998-09-01
Combivir
Indication: HIV Infection
Start date: 2005-09-28
End date: 2006-06-23
Epivir
Indication: HIV Infection
Start date: 1998-04-01
Invirase
Indication: HIV Infection
Start date: 2006-06-23
Lyrica
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
End date: 2006-07-01
Neurontin
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
End date: 2006-01-01
Norvir
Indication: HIV Infection
Start date: 2004-04-17
Retrovir
Indication: HIV Infection
Start date: 2006-06-23
Telzir
Indication: HIV Infection
Start date: 2005-03-29
End date: 2006-06-23
Viread
Indication: HIV Infection
Start date: 2006-06-23
Other drugs received by patient: Viracept; Zerit
Adverse event in 46 year old male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09
Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Coronary Artery Disease
Adverse event resulted in: disablity
Suspect drug(s):
Combivir
Indication: HIV Infection
Start date: 2005-01-31
End date: 2005-09-21
Invirase
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Kaletra
Indication: HIV Infection
Start date: 2005-01-31
Norvir
Indication: HIV Infection
Start date: 2006-01-11
Trizivir
Indication: HIV Infection
Start date: 2005-09-21
Zerit
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Adverse event in 46 year old male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09
Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Coronary Artery Disease
Adverse event resulted in: disablity
Suspect drug(s):
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-31
End date: 2005-09-21
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-31
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-01-11
Norvir
Administration route: Oral
Start date: 1998-12-30
End date: 2004-10-25
Trizivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-09-21
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Other drugs received by patient: Zelitrex; Escitalopram; Seresta
Adverse event in 38 year old female receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from Finland on 2007-10-03
Patient: 38 year old female
Adverse reactions / side effects: Abortion Spontaneous
Adverse event resulted in: hospitalization
Suspect drug(s):
Combivir
Dosage: frequency reported as 1x2
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-18
Invirase
Dosage: frequency reported as 2x2
Administration route: Oral
Indication: HIV Infection
Start date: 2006-06-11
Norvir
Dosage: frequency reported as 1x2
Administration route: Oral
Indication: HIV Infection
Start date: 2007-06-11
Viracept
Dosage: frequency reported as 5x2
Administration route: Oral
Indication: HIV Infection
Start date: 2003-06-18
End date: 2007-06-11
Adverse event in 46 year old male receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from France on 2007-10-01
Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Cardiac Disorder
Adverse event resulted in: disablity
Suspect drug(s):
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-31
End date: 2005-09-21
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Kaletra
Dosage: 4tab twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-01-31
Norvir
Dosage: 100mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-01-11
Trizivir
Dosage: 1tab twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-09-21
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-30
End date: 2004-10-25
Other drugs received by patient: Zelitrex; Escitalopram; Seresta
Adverse event in male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-27
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Diaphragmatic Hernia
Suspect drug(s):
Fuzeon
Dosage: exposure dates: 35 weeks to delivery.
Indication: Systemic Antiviral Treatment
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: exposure dates: prior to conception to 30 weeks.
Indication: Systemic Antiviral Treatment
End date: 2005-02-18
Lamivudine
Dosage: exposure dates: prior to conception to 30 weeks.
Indication: Systemic Antiviral Treatment
Start date: 2004-07-29
End date: 2005-02-16
Ritonavir
Dosage: exposure dates: prior to conception to 30 weeks.
Indication: Systemic Antiviral Treatment
Start date: 2004-07-29
End date: 2005-02-16
Tenofovir Disoproxil Fumarate
Dosage: exposure dates: prior to conception to delivery.
Indication: Systemic Antiviral Treatment
Start date: 2004-07-29
ZDV + DDC VS ZDV + 3TC VS ZDV + 3TC
Dosage: exposure dates: 30 weeks to delivery.
Indication: Systemic Antiviral Treatment
Start date: 2005-02-16
Adverse event in male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-26
Patient: male
Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Hydronephrosis, Delivery
Suspect drug(s):
Combivir
Dosage: 2tabs per day
Indication: HIV Infection
Start date: 2006-04-25
Invirase
Dosage: 2000mg per day
Indication: HIV Infection
Start date: 2006-04-25
Norvir
Dosage: 200mg per day
Indication: HIV Infection
Start date: 2006-04-25
Adverse event in male receiving Invirase (Saquinavir)
Reported by a physician from France on 2007-07-25
Patient: male
Adverse reactions / side effects: Cytolytic Hepatitis
Suspect drug(s):
Invirase (Saquinavir)
Adverse event in 38 year old female receiving Invirase (Saquinavir)
Reported by a physician from Switzerland on 2007-07-24
Patient: 38 year old female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Coagulation Factor Decreased, Jaundice, Encephalopathy, Hepatocellular Damage
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Invirase
Dosage: taken in the evening.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-08-01
End date: 2007-02-02
Kivexa
Dosage: taken in the evening.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-08-01
End date: 2007-02-02
Other drugs received by patient: Ortho Evra; Norvir; Itinerol B6
Adverse event in 38 year old female receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from Switzerland on 2007-07-23
Patient: 38 year old female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Antinuclear Antibody Increased, Jaundice, Hepatic Necrosis, Hepatic Failure, Transaminases Increased, Abdominal Pain Upper, Abdominal Discomfort, Hepatic Encephalopathy, Gallbladder Disorder, Menorrhagia, Vomiting, Nausea, Haematuria, Encephalopathy, Hepatocellular Damage, Coagulation Factor Decreased, Diarrhoea, Prothrombin Time Shortened, Gastroenteritis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Invirase
Dosage: 1000mg twice per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-08-01
End date: 2007-02-02
Kivexa
Dosage: 900mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-08-01
End date: 2007-02-02
Other drugs received by patient: Ortho Evra; Norvir
Adverse event in 27 year old female receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18
Patient: 27 year old female
Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection
Suspect drug(s):
Combivir
Dosage: 900mg per day
Administration route: Oral
Start date: 2005-02-16
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2004-07-29
End date: 2005-02-16
Fuzeon
Dosage: 180mg per day
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: 2000mg per day
Start date: 2004-09-29
End date: 2005-02-16
Norvir
Dosage: 400mg per day
Start date: 2004-07-29
End date: 2005-02-16
Viread
Dosage: 300mg per day
Start date: 2004-07-29
Adverse event in male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Diaphragmatic Hernia
Suspect drug(s):
Combivir
Dosage: 900mg per day
Start date: 2005-02-16
Epivir
Dosage: 300mg per day
Start date: 2004-07-29
End date: 2005-02-16
Fuzeon
Dosage: 180mg per day
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: 2000mg per day
Start date: 2004-09-29
End date: 2005-02-16
Norvir
Dosage: 400mg per day
Start date: 2004-07-29
End date: 2005-02-16
Viread
Dosage: 300mg per day
Start date: 2004-07-29
Adverse event in male receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-17
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Diaphragmatic Hernia
Suspect drug(s):
Fuzeon
Dosage: exposure dates: 35 weeks to delivery.
Indication: Systemic Antiviral Treatment
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: exposure dates: prior to conception to 30 weeks.
Indication: Systemic Antiviral Treatment
End date: 2005-02-18
Other drugs received by patient: Tenofovir Disoproxil Fumarate; Ritonavir; Lamivudine; ZDV + DDC VS ZDV + 3TC VS ZDV + 3TC
Adverse event in 17 year old male receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from United Kingdom on 2007-07-17
Patient: 17 year old male
Adverse reactions / side effects: Hyperlipidaemia, Pancreatitis Haemorrhagic, Type 1 Diabetes Mellitus
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Dosage: stopped 20-sep-2002 restarted 13-mar-2003.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-11-14
Invirase
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-09-02
End date: 2000-11-13
Lamivudine
Dosage: 01nov98 to unk;unk to 31oct1999 started 26jun2000 to 28jan2000, stopped 20sep2002; 27feb2003on
Administration route: Oral
Indication: HIV Infection
Start date: 1996-11-21
End date: 1999-09-30
Norvir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-09-02
End date: 2000-11-13
Videx
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-10-01
End date: 2000-05-02
Zerit
Dosage: stopped feb 17-1999, restarted 12-sep-1999
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1997-09-11
End date: 2002-09-20
Zerit
Dosage: stopped feb 17-1999, restarted 12-sep-1999
Administration route: Oral
Indication: HIV Infection
Start date: 1997-09-11
End date: 2002-09-20
Other drugs received by patient: Loxonin; Selbex; Diflucan; Baktar; Factor IX Complex; Zidovudine; Camostat Mesylate
Adverse event in male receiving Invirase (Saquinavir)
Reported by a physician from Switzerland on 2007-07-16
Patient: male, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Klinefelter's Syndrome
Suspect drug(s):
Invirase (Saquinavir)
Other drugs received by patient: Norvir; Combivir; Zyprexa; Amoxicillin
Adverse event in female receiving Invirase (Saquinavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-16
Patient: female, weighing 2.2 kg (4.8 pounds)
Adverse reactions / side effects: Abdominal Distension
Adverse event resulted in: hospitalization
Suspect drug(s):
Combivir
Dosage: start at least in 1998.
Start date: 1998-01-01
End date: 2007-04-30
Invirase
Start date: 2007-04-30
End date: 2007-05-26
Kaletra
Start date: 2004-01-01
End date: 2007-05-26
Other drugs received by patient: TB Medication; Spasfon
Adverse event in 47 year old male receiving Invirase (Saquinavir)
Reported by a physician from United States on 2007-07-12
Patient: 47 year old male, weighing 73.9 kg (162.7 pounds)
Adverse reactions / side effects: Dermatitis Allergic, Pancreatitis Acute, Hiatus Hernia, Urine Output Decreased, Hepatic Steatosis, Haemoglobin Decreased, Portal Hypertensive Gastropathy, Platelet Count Decreased, Blood Creatinine Increased, Rebound Effect, Splenomegaly
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: 800 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Emtriva
Dosage: 200 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2006-03-10
End date: 2006-12-18
Invirase
Dosage: 2000 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-30
End date: 2006-12-18
Norvir
Dosage: 200 mg/bid/po; 100 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-01
End date: 2005-05-04
Norvir
Dosage: 200 mg/bid/po; 100 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Placebo
Dosage: po; po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Placebo
Dosage: po; po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
Truvada
Dosage: 1 tablet/daily/po; 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Truvada
Dosage: 1 tablet/daily/po; 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-03-09
Vicks INH
Dosage: 4 puff/daily/inh
Indication: Sinus Congestion
Start date: 2007-01-10
End date: 2007-01-12
Zidovudine
Dosage: 300 mg/bid/po; 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Zidovudine
Dosage: 300 mg/bid/po; 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Other drugs received by patient: Feldene; Feldene; Feldene; Lomotil; Lopid; Neurontin; Nicoderm; Oxandrin; Oxycontin; Oxycontin; Oxycontin; Phenergan (Promethazine Hydrochl; Protonix; Roxicodone; Senokot; Zantac 150; [therapy Unspecified]; Acetaminophen (+) Phenylephrine; Dextrose 5% and Sodium Chloride 0.45% IN Plastic Container; Docusate Sodium; Fenofibrate; Hydromorphone Hydrochloride; Magnesium Sulfate; Pentamidine Isethionate; Prochlorperazine; Sodium Chloride
Adverse event in 23 year old female receiving Invirase (Saquinavir)
Reported by a individual with unspecified qualification from United States on 2007-07-10
Patient: 23 year old female
Adverse reactions / side effects: Hydronephrosis
Suspect drug(s):
Invirase
Indication: Drug USE FOR Unknown Indication
Lamivudine
Indication: Drug USE FOR Unknown Indication
Norvir
Indication: Drug USE FOR Unknown Indication
Zidovudine
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Invirase (Saquinavir)
Reported by a consumer/non-health professional from France on 2007-06-26
Patient: female, weighing 91.0 kg (200.2 pounds)
Adverse reactions / side effects: Anaemia, Cholestasis, Premature Labour, Transaminases Increased, Hepatocellular Damage, Vaginal Candidiasis, Drug Exposure During Pregnancy, Albuminuria, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Combivir
Dosage: 1tab twice per day
Administration route: Oral
Indication: HIV Infection
End date: 2007-04-30
Invirase
Dosage: 2cap twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-30
End date: 2007-05-26
Kaletra
Dosage: 2tab twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-01
End date: 2007-05-26
Other drugs received by patient: Spasfon; Tardyferon B9
|
